Previous close | 8.90 |
Open | 8.91 |
Bid | 8.70 x 900 |
Ask | 8.72 x 1400 |
Day's range | 8.40 - 9.00 |
52-week range | 4.00 - 9.86 |
Volume | |
Avg. volume | 391,217 |
Market cap | 260.01M |
Beta (5Y monthly) | 0.09 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Neurocrine (NBIX) delivered earnings and revenue surprises of -9.89% and 4.01%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?